Ackermann, Deonna M.
Smit, Amelia K.
Janda, Monika
van Kemenade, Cathelijne H.
Dieng, Mbathio
Morton, Rachael L.
Turner, Robin M.
Cust, Anne E.
Irwig, Les
Hersch, Jolyn K.
Guitera, Pascale
Soyer, H. Peter
Mar, Victoria
Saw, Robyn P. M.
Low, Donald
Low, Cynthia
Drabarek, Dorothy
Espinoza, David
Emery, Jon
Murchie, Peter
Thompson, John F.
Scolyer, Richard A.
Azzi, Anthony
Lilleyman, Alister
Bell, Katy J. L. http://orcid.org/0000-0002-0137-3218
Funding for this research was provided by:
National Health and Medical Research Council (APP1163054)
Article History
Received: 21 February 2021
Accepted: 27 March 2021
First Online: 4 May 2021
Declarations
:
: The protocol, statistical analysis plan, data safety management plan, informed consent forms and participant education and recruitment materials have been reviewed and approved by Sydney Local Health District (RPAH Zone) Ethics committee (X20-0106 and 2019/ETH13612). Any subsequent modifications will be submitted for review, and annual safety and progress reports will be presented. Informed consent will be obtained from all participants.
: No details or images relating to an individual person will be published. All data will be presented in aggregate form. A model consent form is available on request.
: HPS is a shareholder of MoleMap NZ Limited and e-derm consult GmbH and undertakes regular teledermatological reporting for both companies. HPS is a Medical Consultant for Canfield Scientific Inc., MetaOptima and Revenio Research Oy and a Medical Advisor for First Derm. PG receives a consultancy honorarium from MetaOptima. RPMS has received honoraria for advisory board participation from MSD, Novartis and Qbiotics and speaking honoraria from BMS. JFT has received honoraria for advisory board participation from BMS Australia, MSD Australia, GSK and Provectus Inc., and travel support from GSK and Provectus Inc. RAS has received fees for professional services from Qbiotics, Novartis, Merck Sharp & Dohme, NeraCare, AMGEN Inc., Bristol-Myers Squibb, Myriad Genetics, GlaxoSmithKline.